Showing results (171-180 of 204) with videos related to
Sort By:
Pageof 21
The Pediatric Infectious Disease Journal|May 15, 2021
Blastomycosis in 64 Wisconsin Children: Unanticipated Infection Risk and Severity in Urban ResidentsJaimee M Hall, Peter L Havens, Errin A Mitchell, et al.Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.Investigative Ophthalmology & Visual Science|February 17, 2009
Replication of the recessive STBMS1 locus but with dominant inheritanceAine Rice, Jérémie Nsengimana, Ian G Simmons, et al.Italian Journal of Dermatology and Venereology|March 20, 2023
Next generation sequencing panel target genes: possible diagnostic tool for ectodermal dysplasia related diseasesMichele Callea, Emanuele Bellacchio, Francisco Cammarata Scalisi, et al.Journal of Proteome Research|November 21, 2012
Metabolomics of cerebrospinal fluid from humans treated for rabiesAifric O'Sullivan, Rodney E Willoughby, Darya Mishchuk, et al.Brain : a Journal of Neurology|June 4, 1999
Development of a multiple sclerosis functional composite as a clinical trial outcome measureG R Cutter, M L Baier, R A Rudick, et al.Hepatology (Baltimore, Md.)|June 22, 2021
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular CarcinomaLaura Torrens, Carla Montironi, Marc Puigvehí, et al.Plos Neglected Tropical Diseases|December 18, 2018
NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous systemCaitlin D French, Rodney E Willoughby, Amy Pan, et al.Journal for Immunotherapy of Cancer|January 11, 2021
Domain binding and isotype dictate the activity of anti-human OX40 antibodiesJordana Griffiths, Khiyam Hussain, Hannah L Smith, et al.Pageof 21